Invited Commentary

Commentary on “Antithrombotic Therapy Practices in Older Adults Residing in the Long-Term Care Setting”

Authors: James M. Wooten, PharmD

Abstract

In this issue of the Southern Medical Journal, Kozikowski and colleagues present a retrospective review that attempts to explore the pattern of antiplatelet/anticoagulant use by physicians when caring for older adult patients in a long-term care facility.1 The information collected by the researchers illustrates that physicians have varied patterns of antiplatelet/anticoagulant usage that depends on factors including the patient’s general health status, comorbidities, and other medications.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Oo W, Kozikowski A, Stein J, et al. Antithrombotic therapy practices in older adults residing in the long-term care setting. South Med J 2015; 108:437-438.
 
2. Wooten JM. Pharmacotherapy considerations in elderly adults. South Med J 2012;105:437-445.
 
3. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-631.
 
4. ShoebM, FangMC. Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis 2013;35:3-319.
 
5. Carlquist JF, Anderson JL. Using pharmacogenetics in real time to guide warfarin initiation: a clinician update. Circulation 2011;124:2554-2559.
 
6. McKowen LA. Real-world studies highlight GI bleeding concerns with newer anticoagulants. http://www.tctmd.com/show.aspx?id=128617. Accessed June 9, 2015.
 
7. Abraham NS, Singh S, Alexander GC, et al. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ 2015;350:h1857.